Browse Category

TSX:WEED 6 December 2025 - 24 December 2025

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth shares closed at $1.40 on Dec. 23, up 6.06%, after heavy trading and sharp swings throughout December. The volatility followed a Dec. 18 White House executive order directing marijuana rescheduling from Schedule I to III. Trading volume spiked to over 216 million shares on Dec. 18, with implied volatility near 143%. U.S. exchanges operated a shortened session on Dec. 24.
Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth shares jumped about 21% in premarket trading Friday after reports said President Trump is expected to direct federal agencies to reclassify marijuana as a Schedule III drug. The move, first reported by the Washington Post and cited by Reuters, triggered a surge across US-listed cannabis stocks. No final decision has been made, according to a White House official.
Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth shares closed at $1.15 on December 5, down 4.96%, but remain up about 13–14% over the last 10 sessions. Q2 FY2026 net revenue rose 6% to C$66.7 million, with gross margin improving to 33%. Net loss narrowed sharply to C$1.6 million from C$131.6 million a year earlier. The company ended the quarter with C$298 million in cash, exceeding its total debt.
Go toTop